Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of Ctrl and NaBu-treated CD8+ T cells in vitro

ABSTRACT: RNA-seq of Ctrl and NaBu-treated CD8+ T cells in vitro

PROVIDER: PRJNA474935 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7274746.fastq.gz	Fastqsanger.gz
	SRR7274747.fastq.gz	Fastqsanger.gz
	SRR7274748.fastq.gz	Fastqsanger.gz
	SRR7274749.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

RNA sequencing of splenic CD8+ T cells treated with AAV-IL-27/ctrl in vivo

Project description:Splenic CD8+ T cells of C57BL/6 mice treated with AAV-IL-27/ctrl for a month were sepreated by MACS. Transcriptome profiling (RNA-seq) of these purified CD8+ T cells (>95%) was completed by BGI. Changing in gene express profiling resulted by IL-27 was analyzed in this study.

2022-02-01 | GSE195736 | GEO

RNA-seq of Ctrl and NaBu-treated CD8+ T cells in vitro

Project description:Recent studies in both mice and human have suggested that the gut microbiota could modulate tumor response to chemotherapeutic agents or immunotherapies. However, the underlying mechanism has not been well characterized. Here, we found that disruption of the intestinal microbiota with antibiotics impaired the anti-cancer efficacy of oxaliplatin, which was correlated with the reduction of lots of the intestinal microbial metabolites including butyrate, one of the short chain fatty acids. Re-supplementation of either the whole intestinal microbial metabolites or butyrate could rescue the therapeutic responses of oxaliplatin in the microbiota-destroyed tumor-bearing mice by modulating CD8+ T cell function in the tumor microenvironment. Further experiments showed butyrate boosted the anti-tumor cytotoxic CD8+ T cell responses through ID2, a key transcription regulator highly expressed by tumor-infiltrating CD8+ T cells. Butyrate induced ID2 expression in CD8+ T cells, while ID2 further promoted the proliferation and function of CD8+ T cells through IL-12 signaling. Together, our findings suggest that gut microbial metabolite butyrate could promote the anti-tumor therapeutic efficacy through the ID2-dependent regulation of CD8+ T cell immunity.

2021-03-24 | GSE115426 | GEO

RNA sequencing of splenic CD8+ T cells treated with AAV-IL-27/ctrl in vivo

Project description:RNA sequencing of splenic CD8+ T cells treated with AAV-IL-27/ctrl in vivo

| PRJNA802038 | ENA

RNA-seq of control and DOPAC-treated CD8+ T cells in vitro

Project description:RNA-seq of control and DOPAC-treated CD8+ T cells in vitro

| PRJNA1212056 | ENA

CD8 T cells isolated from treated mice

Project description:CD8 T cells isolated from blood of mice treated with radiation therapy and immunotherapy

2024-06-20 | PXD043110 | JPOST Repository

RNA-seq of control and DOPAC-treated CD8+ T cells in vitro

Project description:To investigate the effect of DOPAC on CD8+ T cells function, CD8+ T cells were treated with DOPAC for bulk RNA sequcecing.

2025-01-21 | GSE287296 | GEO

In vitro generation of CD8 Trm cells

Project description:In vitro generation of CD8 Trm cells

| PRJNA974072 | ENA

RNA sequencing analysis of intracranial D425 xenografts treated with ASO-CTRL and ASO-lnc-HLX 2-7

Project description:To gain more insights into the functional significance of lnc-HLX-2-7, gene expression profiles were measured using D425 (sh-CTRL), D425 (sh-HLX) and intracranial D425 xenografts treated with ASO-CTRL and ASO-lnc-HLX 2-7 by RNA sequencing.

2023-11-01 | GSE188746 | GEO

Murine CD8+ T cells: in vitro-derived vs. thymocytes

Project description:Transcriptional profiling of mouse in-vitro derived CD8+ cells (obtained after culturing BM-HSCs isolated from B6 mice) with OP9-DL1 cells for 35 days were compared to CD8+ thymocytes isolated from 4-5 weeks old B6 mice. Our goal was to determine similarities and differences in gene expression profile between in vitro-derived CD8+ cells and CD8+ cells isolated from the thymus. The procedure of in vitro differentiation of HSC using OP9-DL1 cocultures was previously described by: Schmitt, T. M., and J. C. Zuniga-Pflucker. 2002. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749-756 and Holmes, R., and J. C. Zuniga-Pflucker. 2009. The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro. Cold Spring Harb Protoc 2009:pdb prot5156. Biological replicates: 2 different samples of in vitro-derived CD8+ T cells from day 35 were compared to 2 different samples of thymic CD8+ cells.

2012-09-05 | E-GEOD-37669 | biostudies-arrayexpress

Single-cell RNA sequencing of T3 sarcoma tumors following treatment with CD8-mIL2, CTRL-not-alpha-mIL2, or anti-PD-1

Project description:To assess treatment-induced changes of intratumoral CD8+ T cells in an unbiased manner, CD8+ TILs from T3 sarcomas were analyzed using single-cell RNA-sequencing (scRNAseq) 2 or 4 days after therapy with CD8-mIL2, CTRL-not-α-mIL2, anti-PD-1, or combinations thereof. Barcoded peptide:MHC reagents were included to identify mLama4-specific CD8+ T cells. CD8-mIL2 therapy promotes the generation of a new stem-like effector CD8+ T cell cluster with a signature indicative of polyfunctionality and with features of T cell memory.

2024-04-02 | GSE252650 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data